loader
Please Wait
Applying Filters...
Close
4

CF Pharma Cisatracurium Besylate Header CF Pharma Cisatracurium Besylate Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of USP reference standards related to Cisatracurium Besylate

    Client Email Product
    Menu

    Cisatracurium Besylate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 1134118 (1)

    02 1134131 (1)

    filter

    01 Cisatracurium Besylate (350 mg) (1)

    02 Cisatracurium Besylate System Suitability Mixture (20 mg) (1)

    filter

    01 96946-42-8 (1)

    02 N/A (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    USP

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Cisatracurium Besylate System Suitability Mixture (20 m...

      PDF Supplier PDF
      URL Supplier Web Content
      1134131
      N/A
      F0M559
      730
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      USP

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Cisatracurium Besylate (350 mg)

        PDF Supplier PDF
        URL Supplier Web Content
        1134118
        96946-42-8
        R06160
        F0M554 (28-FEB-2018)
        1015
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Post Enquiry
        POST ENQUIRY